ES2197840T1 - Metodo para producir y usar nuevas defensinas humanas como proteinas biologicamente activas para tratar infecciones y otras enfermedades. - Google Patents

Metodo para producir y usar nuevas defensinas humanas como proteinas biologicamente activas para tratar infecciones y otras enfermedades.

Info

Publication number
ES2197840T1
ES2197840T1 ES01969365T ES01969365T ES2197840T1 ES 2197840 T1 ES2197840 T1 ES 2197840T1 ES 01969365 T ES01969365 T ES 01969365T ES 01969365 T ES01969365 T ES 01969365T ES 2197840 T1 ES2197840 T1 ES 2197840T1
Authority
ES
Spain
Prior art keywords
fragments
derivatives
diseases
producing
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES01969365T
Other languages
English (en)
Other versions
ES2197840T3 (es
Inventor
Wolf-Georg Forssmann
Jose-Ramon Conejo-Garcia
Knut Adermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPF Pharmaceuticals GmbH
Original Assignee
IPF Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPF Pharmaceuticals GmbH filed Critical IPF Pharmaceuticals GmbH
Publication of ES2197840T1 publication Critical patent/ES2197840T1/es
Application granted granted Critical
Publication of ES2197840T3 publication Critical patent/ES2197840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Péptidos con la secuencia de aminoácidos ZN-C-Xm-X1-X-C-X2-Xn-C-X-X-X-X3-Xo-C-Xp-C-C-Zc siendo ZN un radical aminoácido o un radical péptido de hasta 30 aminoácidos, siendo Zc un radical aminoácido o un radical péptido de hasta 30 aminoácidos, X= un aminoácido arbitrario Xm= 3-6 aminoácidos arbitrarios Xn= 2-3 aminoácidos Xo= 5-9 aminoácidos Xp= 4-6 aminoácidos X1=G, A o P X2=R, K, W, Q o A X3= E o H.
ES01969365T 2000-07-11 2001-07-11 Procedimiento para la obtencion y uso de nuevas defensinas humanas como proteinas biologicamente activas para el tratamiento de infecciones y otras enfermedades. Expired - Lifetime ES2197840T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10033505 2000-07-11
DE10033505 2000-07-11

Publications (2)

Publication Number Publication Date
ES2197840T1 true ES2197840T1 (es) 2004-01-16
ES2197840T3 ES2197840T3 (es) 2008-03-16

Family

ID=7648436

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01969365T Expired - Lifetime ES2197840T3 (es) 2000-07-11 2001-07-11 Procedimiento para la obtencion y uso de nuevas defensinas humanas como proteinas biologicamente activas para el tratamiento de infecciones y otras enfermedades.

Country Status (11)

Country Link
US (2) US20040116652A1 (es)
EP (2) EP1299541B1 (es)
JP (1) JP2004504017A (es)
AT (1) ATE373091T1 (es)
AU (1) AU2001289641A1 (es)
CA (1) CA2427066A1 (es)
DE (1) DE50113010D1 (es)
DK (1) DK1299541T3 (es)
ES (1) ES2197840T3 (es)
PT (1) PT1299541E (es)
WO (1) WO2002004487A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576755B1 (en) 1997-09-10 2003-06-10 Zymogenetics, Inc. Beta-defensins
EP1878794A3 (en) * 1999-11-30 2008-01-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
AU2001275208A1 (en) * 2000-06-01 2001-12-11 University Of Iowa Research Foundation Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
WO2002040512A2 (de) * 2000-11-14 2002-05-23 Ipf Pharmaceuticals Gmbh Humanes beta-defensin-3
KR20050089827A (ko) * 2002-12-19 2005-09-08 이츠차크 힐만 항균성 펩티드 억제물을 통한 질환 치료
GB0300718D0 (en) 2003-01-13 2003-02-12 Ares Trading Sa Proteins
FR2879203A1 (fr) * 2004-12-09 2006-06-16 Univ Rennes I Etablissement Pu Peptides antimicrobiens, polypeptides comprenant lesdits peptides, procedes pour les preparer, genes codant pour lesdits peptides, vecteurs, organismes transformes et compositions les contenant
US9044438B2 (en) 2005-06-17 2015-06-02 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US8202835B2 (en) 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
GB0514482D0 (en) * 2005-07-14 2005-08-17 Ares Trading Sa Protein
CN102198264B (zh) * 2010-03-23 2013-10-09 中国科学院上海生命科学研究院 大鼠附睾特异抗菌肽β-防御素15及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69831084T2 (de) * 1997-09-10 2006-06-01 Zymogenetics, Inc., Seattle Beta-defensine
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
ATE291586T1 (de) * 1999-02-01 2005-04-15 Schering Ag Humanes antibiotisches protein
WO2001049702A1 (en) * 2000-01-05 2001-07-12 Emory University Epididymal antimicrobial peptides

Also Published As

Publication number Publication date
AU2001289641A1 (en) 2002-01-21
ES2197840T3 (es) 2008-03-16
EP1299541B1 (de) 2007-09-12
US20040116652A1 (en) 2004-06-17
JP2004504017A (ja) 2004-02-12
WO2002004487A3 (de) 2002-09-19
ATE373091T1 (de) 2007-09-15
DK1299541T3 (da) 2008-01-21
EP1887015A2 (de) 2008-02-13
EP1299541A2 (de) 2003-04-09
DE50113010D1 (de) 2007-10-25
US20090124541A1 (en) 2009-05-14
CA2427066A1 (en) 2003-02-24
WO2002004487A2 (de) 2002-01-17
PT1299541E (pt) 2007-10-01
EP1887015A3 (de) 2008-05-07

Similar Documents

Publication Publication Date Title
CA2032059C (en) Wound treatment employing biologically active peptides
ES2197840T1 (es) Metodo para producir y usar nuevas defensinas humanas como proteinas biologicamente activas para tratar infecciones y otras enfermedades.
KR100891157B1 (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
ES2784484T3 (es) Péptido antimicrobiano
Casciaro et al. Promising approaches to optimize the biological properties of the antimicrobial peptide esculentin-1a (1–21) NH2: amino acids substitution and conjugation to nanoparticles
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
DE60035337D1 (de) Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoide Tumorzellen, herbeiführen oder bewirken
ATE362485T1 (de) Alloferone - immunomodulierende peptide
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
JP2005506300A5 (es)
DK1539964T3 (da) Cellectin-komplementaktiverende proteinkimærer
Casciaro et al. The Potential of frog skin peptides for anti-Infective therapies: the Case of Esculentin-1a (1-21) NH2
JPH07501519A (ja) 生物活性両親媒性ペプチド組成物およびその用途
Chen et al. Purification and characterization of an antibacterial and anti-inflammatory polypeptide from Arca subcrenata
CN101679495B (zh) 用于细胞学和免疫学调节的短的生物活性肽
CA2371794C (en) Human antibiotic proteins
JPH07502979A (ja) 生物活性ペプチドを利用する口腔内の有害な状態の予防と治療
US20150218233A1 (en) Synthetic pntx(19) peptide, pharmaceutical compositions and use
ATE490324T1 (de) Nukleinsäuren kodierend für polypeptide mit chips aktivität
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
Schröder et al. Antimicrobial peptides in skin disease
AR013886A1 (es) Proteinas utiles para tratar la obesidad y condiciones asociadas con la obesidad; composiciones farmaceuticas formuladas con dichas proteinas;compuestos polinucleoticos de dna que codifican dichas proteinas y procedimiento para pepararlas
KR20130109543A (ko) 황다랑어 유래의 새로운 항미생물성 펩타이드 및 이의 용도
ES2199098T1 (es) Metodo para la extraccion y uso de peptidos que son activos como antibioticos para tratar enfermedades infecciosas.
DK0811068T3 (da) Humane DNase I varianter